Search Results - "Kolomatsky, V V"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    MOLECULAR MECHANISMS OF INHIBITION OF COLLAGEN CLEAVAGE ACTIVITY BY DEFEROXAMINE IN THE CARTILAGE OF PATIENTS WITH OSTEOARTHRITIS by Chetina, E. V., Markova, G. A., Logunov, A. L., Kolomatsky, V. V., Naryshkin, E. A., Makarov, S. A., Kuzin, A. N.

    “…Objective: to study the molecular mechanisms underlying the suppression of collagenase activity in the presence of deferoxamine (DFO) in articular cartilage…”
    Get full text
    Journal Article
  2. 2

    Molecular mechanisms of pain regulation in patients with osteoarthritis by Chetina, E. V., Markova, G. A., Taskina, E. A., Sharapova, E. P., Kashevarova, N. G., Alekseeva, L. I., Kolomatsky, V. V., Makarov, M. A., Logunov, A. L., Makarov, S. A., Kuzin, A. N.

    “…Objective: to study the mechanisms determining the level of pain on the basis of an analysis of the expression profiles of the genes involved in joint…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Enhanced regulatory gene expressions in the blood and articular cartilage of patients with rheumatoid arthritis by Chetina, Elena Vasilyevna, Semyonova, L A, Logunov, A L, Kolomatsky, V V, Makarov, M A, Roskidailo, A A, Naryshkin, E A, Makarov, S A

    “…Objective: to study the expression ratio of the non-tissue specific regulatory genes mTOR, р21, ATG1, caspase 3, tumor necrosis factor-а (TNF-а), and…”
    Get full text
    Journal Article
  5. 5

    High-technology surgical methods in the comprehensive medical rehabilitation of patients with rheumatic diseases and joint pathology of the upper and lower extremities by Vadim Petrovich Pavlov, S A Makarov, M A Makarov, A L Logunov, Ya B Khrennikov, V V Kolomatsky, M M Lipina, A A Roskidailo, D V Ivanov

    Published in Sovremennai͡a︡ revmatologii͡a (12-06-2012)
    “…A large clinical material (1693 patients with rheumatic diseases — RD, 2066 operations) was used to develop a three-level medical rehabilitation system using…”
    Get full text
    Journal Article
  6. 6

    PREDICTION OF THE COURSE OF OSTEOARTHROSIS FROM mTOR (MAMMALIAN TARGET OF RAPAMYCIN) GENE EXPRESSION by Chetina, E V, Bratygina, E A, Zaitseva, E M, Sharapova, E P, Semenova, L A, Demin, N A, Alekseyeva, L I, Glukhova, S I, Kolomatsky, V V, Makarov, M A, Logunov, A L, Roskidailo, A A, Makarov, S A

    “…Objective: To study whether the course of the disease can be predicted in patients with osteoarthrosis (OA), by monitoring mTOR (Mammalian Target Of Rapamycin)…”
    Get full text
    Journal Article
  7. 7

    SHOULD DISEASE-MODIFYING THERAPY BE STOPPED IN PATIENTS WITH RHEUMATOID ARTHRITIS BEFORE ENDOPROSTHETIC JOINT REPLACEMENT? by Savenkova, N. A., Amirdzhanova, V. N., Makarov, S. A., Logunov, A. L., Makarov, M. A., Kolomatsky, V. V., Goryachev, D. V.

    “…Objective: to analyze disease activity, functional state, quality of life (QL), and the frequency of infectious complications in methotrexate (MT) – or…”
    Get full text
    Journal Article
  8. 8

    Does endoprosthetic replacement of large joints improve quality of life in patients with rheumatoid arthritis? by Savenkova, Nadezhda Alekseevna, Amirdzhanova, V N, Makarov, S A, Logunov, A L, Makarov, M A, Kolomatskiy, V V, Savenkova, Nadezhda Alekseyevna, Kolomatsky, V V

    “…Objective: to analyze the course of rheumatoid arthritis (RA), to assess its previous therapy, and to evaluate the efficiency of endoprosthetic replacement of…”
    Get full text
    Journal Article
  9. 9
  10. 10